Bridgepoint to buy Obagi Medical for up to $460m
Publicly traded global multi-brand beauty and wellness platform Waldencast is selling its Obagi Medical skincare and aesthetics business to the private equity firm Bridgepoint. For Bridgepoint, the acquisition bolsters its expanding track record across the dermatology, aesthetics, and professional skincare ecosystem. Obagi Medical, a pioneer in physician-dispensed skincare, expanded its addressable market through its 2025 acquisition of Novaestiq and the…
EQT and co-investors fully exit Galderma
Swedish private equity firm EQT has fully divested from Swiss-based global pure-play dermatology company Galderma. On March 13, EQT and its co-investors, including the Abu Dhabi Investment Authority and Singapore’s GIC, offloaded their remaining 14.3% stake. The sale of approximately 34 million shares generated roughly 4.9 billion Swiss francs (£4.65bn), making it the largest sponsor-backed block trade in history. The…